Patanjali launches Ayurvedic medicine 'Coronil', claims 100%
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Patanjali on 23rd June 2020 launched 'Coronil and Swasari', what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 percent favorable results during clinical trials on affected patients, at Patanjali Yogpeeth in Haridwar.

Acharya Balkrishna, MD of Patanjali Ayurved, claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 3-14 days.

Highlights from the Patanjali's Coronil kit launch event:

• A total of 100 coronavirus positive patients were recruited for the controlled clinical trial, Patanjali claims. Of which 95 were studied, 1 patient was lost on the follow-up details and 4 patients withdrew consent between the study, claims Patanjali.

• Exclusion criteria for Patanjali clinical study plan (Claimed)
~ Severely symptomatic patients (SaO2 less than 90%)
~ Acute respiratory distress syndrome
~ Life expectancy less than 1 year due to other co-morbid conditions

• Inclusion criteria for Patanjali clinical study plan (Claimed)
~ RT-PCR confirmed cases
~ Age 15-60 years of age

• Patanjali claims:
1) 100% recovery from coronavirus infection within 7 days of treatment with Patanjali Ayurvedic medicines.
2) hsCRP and IL-6 levels were reduced in the treatment group as compared to the placebo group.
3) Ayurvedic treatment showed weaker IL-6 response implicating a lesser chance of cytokine storm.

The Corona kit will be made available at just Rs 545, says Acharya Balkrishna. The corona kit will have medicines for 30 days. This medicine kit is not available anywhere, for now, will be made available at Patanjali stores in a week, says Baba Ramdev.

Dr. A●●●●a A●●●●●●r and 17 others like this32 shares
Dr. T●●●s S●●●●●●●●●a
Dr. T●●●s S●●●●●●●●●a General Medicine
Yes, right.. Multivitamins have the similar effect in the similar inclusion and exclusion criteria.
Jun 23, 2020Like1
Dr. Y●●●●●●r P●●●●●h M●●●●●h
Dr. Y●●●●●●r P●●●●●h M●●●●●h General Medicine
Why not people of below 15 and above 60 years taken under inclusion ...coz they are risk category ?? come we know that this product are curing the disease and not there immunity ?
Jun 23, 2020Like2
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
Interesting read ! However, it is clear that this was tested on asymptomatic patients only. The need for furthur research is very much necessary for the sake of symptomatic patients,as the hospitals are running jam pack with Symptomatic Covid patients. I am confident that Patanjali will,with the permission of Ayush, be able to study more in this area.
Jun 24, 2020Like1